Jon R. Levine

This profile gathers the share dealings of Jon R. Levine in Marimed Inc., where the filings describe the role as finance chief. Between 28 December 2021 and 15 October 2026, the trades on record add up to 29 filings.

Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

The latest filing, published on 15 October 2026, reports an option exercise in Marimed Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.